Skip to content
healthcare.dev

ETCAMAH

NDC 0310-0075, camizestrant, tablet, film coated, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-0075
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA220359
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0075 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAMIZESTRANT75 mg/1
Package NDCNDC-11Package
0310-0075-010031000750128 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-0075-01)
0310-0075-95003100075957 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-0075-95)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c54223d3-f3c7-4186-afa0-429d84805826

Use it

Look up 0310-0075 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0075 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-0075. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.